tiprankstipranks
Trending News
More News >
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Technical Analysis

Compare
4,350 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Recursion Pharmaceuticals’s (RXRX) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Recursion Pharmaceuticals is a Buy.
Recursion Pharmaceuticals’s (RXRX) 20-Day exponential moving average is 4.26, while Recursion Pharmaceuticals’s (RXRX) share price is $3.98, making it a Sell.
Recursion Pharmaceuticals’s (RXRX) 50-Day exponential moving average is 4.46, while Recursion Pharmaceuticals’s (RXRX) share price is $3.98, making it a Sell.

Recursion Pharmaceuticals (RXRX) Pivot Points

Feb 11, 2026, 11:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.44
3.57
3.77
3.90
4.10
4.23
4.43
Fibonacci
3.57
3.69
3.77
3.90
4.02
4.10
4.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Recursion Pharmaceuticals (RXRX) Moving Averages

Feb 11, 2026, 11:02 PM
Period
Simple
Exponential
MA5
3.90Buy
3.96Buy
MA10
4.13Sell
4.10Sell
MA20
4.41Sell
4.26Sell
MA50
4.45Sell
4.46Sell
MA100
4.81Sell
4.70Sell
MA200
4.96Sell
5.08Sell
Recursion Pharmaceuticals’s (RXRX) 10-Day exponential moving average is 4.10, while Recursion Pharmaceuticals’s (RXRX) share price is $3.98, making it a Sell.
Recursion Pharmaceuticals’s (RXRX) 100-Day exponential moving average is 4.70, while Recursion Pharmaceuticals’s (RXRX) share price is $3.98, making it a Sell.
Recursion Pharmaceuticals’s (RXRX) stock price is $3.98 and Recursion Pharmaceuticals’s (RXRX) 50-day simple moving average is 4.45, creating a Sell signal.
Recursion Pharmaceuticals’s (RXRX) stock price is $3.98 and Recursion Pharmaceuticals’s (RXRX) 100-day simple moving average is 4.81, creating a Sell signal.
Recursion Pharmaceuticals’s (RXRX) stock price is $3.98 and Recursion Pharmaceuticals’s (RXRX) 200-day simple moving average is 4.96, creating a Sell signal.

Recursion Pharmaceuticals (RXRX) Technical Indicators

Feb 11, 2026, 11:02 PM
Name
Value
Implied Action
RSI (14)
41.95
Neutral
STOCH (9,6)
26.11
Neutral
STOCHRSI (14)
17.65
Buy
MACD (12,26)
-0.17
Buy
ADX (14)
18.75
Buy
Williams %R
-74.12
Buy
CCI (14)
-103.35
Buy
ATR (14)
0.29
-
Ultimate Oscillator
47.93
Neutral
ROC
-9.55
Sell
Recursion Pharmaceuticals’s (RXRX) Relative Strength Index (RSI) is 41.95, creating a Neutral signal.
Recursion Pharmaceuticals’s (RXRX) Trend Strength Indicator (ADX) is 18.75, creating a Buy signal.
Recursion Pharmaceuticals’s (RXRX) Commodity Channel Index (CCI) is -103.35, creating a Buy signal.
Recursion Pharmaceuticals’s (RXRX) Price Rate of Change (ROC) is -9.55, creating a Sell signal.

FAQ

Is RXRX a Buy, Hold, or Sell?
Based on RXRX’s technical indicators, RXRX is a Sell.
    What is RXRX’s RSI (14)?
    RXRX’s RSI (14) is 41.95, which suggests RXRX is a Neutral.
      What is RXRX’s MACD?
      RXRX’s MACD is -0.17, which suggests RXRX is a Buy.
        What is RXRX’s 5-day moving average?
        RXRX’s 5-day moving average is 3.90, which suggests RXRX is a Buy.
          What is RXRX’s 20-day moving average?
          RXRX 20-day moving average is 4.41, which suggests RXRX is a Sell.
            What is RXRX’s 50-day moving average?
            RXRX’s 50-day moving average is 4.45, which suggests RXRX is a Sell.
              What is RXRX’s 200-day moving average?
              RXRX’s 200-day moving average is 4.96, which suggests RXRX is a Sell.
                What is RXRX’s Williams % R (14)?
                RXRX’s Williams % R (14) is -74.12, which suggests RXRX is a Buy.
                  What is RXRX’s CCI (14)?
                  RXRX’s CCI (14) is -103.35, which suggests RXRX is a Buy.